EUVIMEDEUVIMED entdecken
Crossref

Investigation of a Palbociclib and Naringin Co-Amorphous System to Ameliorate Anticancer Potential: Insights on In Silico Modeling, Physicochemical Characterization, Ex Vivo Permeation, and In Vitro Efficacy

Tanmoy Kanp, Anish Dhuri, Mayur Aalhate, Bharath Manoharan, Khushi Rode, Sharon Munagalasetty, Akella V S Sarma iD, Prasad Kshirsagar, Nagula Shankaraiah iD, Vasundhara Bhandari, Bhagwati Sharma iD, Pankaj Kumar Singh iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.4c01224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Tanmoy Kanp und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana 500037, India. Hauptthemen laut MEDLINE: Flavanones, Pyridines, Antineoplastic Agents, Piperazines. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Palbociclib (PCB), categorized as a BCS class II drug, is characterized by low aqueous solubility. The drug's limited aqueous solubility and poor dissolution rate pose significant challenges, potentially affecting its absorption and overall therapeutic efficacy. Co-amorphous (CAM) systems have been extensively investigated as a potential solution to overcome the issue of poor water solubility in numerous active pharmaceutical ingredients. This research study hypothesized that the coamorphization process involving the compounds PCB and naringin (NG) would lead to an increase in the aqueous solubility of PCB. Additionally, it was proposed that this process would also enhance the anticancer impact of PCB since NG is recognized for its pharmacological impact on breast cancer cells. In silico studies, it was revealed that PCB could interact with NG via hydrogen bonding. Furthermore, the prepared CAM (PCB-NG-CAM) system using PCB and NG was characterized by PXRD, DSC, FTIR, Raman spectroscopy, solid-state 13C nuclear magnetic resonance, and SEM. PCB-NG-CAM exhibited a significant increase in solubility, dissolution rate, and intestinal permeation compared to crystalline PCB. Furthermore, PCB-NG-CAM exhibited excellent physical stability at 40 °C/75% RH for up to 3 months. In addition, PCB-NG-CAM showed superior in vitro efficacy on MDA-MB-231 triple-negative breast cancer cell lines. PCB-NG-CAM resulted in a 2.24 times higher apoptosis rate and a 1.6 times greater ROS production than free PCB. Additionally, the inhibitory effect on cell migration and alterations in MMP was more pronounced in cells treated with PCB-NG-CAM. Therefore, this study indicated that PCB-NG-CAM has the potential to significantly improve the oral administration, solubility, and therapeutic efficacy of PCB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavanonesPyridinesAntineoplastic AgentsPiperazinesHumansSolubilityCell Line, TumorAnimalsComputer SimulationFemaleApoptosisBreast Neoplasms

Stichwörter der Autor:innen

co-amorphousex vivo permeabilityin silico studiesin vitro cell-based studypalbociclibtriple-negative breast cancer

Substanzen

FlavanonesnaringinpalbociclibPyridinesAntineoplastic AgentsPiperazines

Autor:innen und Institutionen

  • Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana 500037, India.
  • Department of Pharmacoinformatic, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana 500037, India.
  • Department of Analytical & Structural Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India.
  • Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana 500037, India.
  • Materials Research Centre, Malaviya National Institute of Technology (MNIT), Jaipur, Rajasthan 302017, India.

ORCID-Profile: Akella V S Sarma, Nagula Shankaraiah, Bhagwati Sharma, Pankaj Kumar Singh

Zitieren

APA

Kanp, T., Dhuri, A., Aalhate, M., Manoharan, B., Rode, K., Munagalasetty, S., Sarma, A. V. S., Kshirsagar, P., Shankaraiah, N., Bhandari, V., Sharma, B., & Singh, P. K. (2025). Investigation of a Palbociclib and Naringin Co-Amorphous System to Ameliorate Anticancer Potential: Insights on In Silico Modeling, Physicochemical Characterization, Ex Vivo Permeation, and In Vitro Efficacy. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01224

Vancouver

Kanp T, Dhuri A, Aalhate M, Manoharan B, Rode K, Munagalasetty S, et al. Investigation of a Palbociclib and Naringin Co-Amorphous System to Ameliorate Anticancer Potential: Insights on In Silico Modeling, Physicochemical Characterization, Ex Vivo Permeation, and In Vitro Efficacy. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01224

BibTeX
@article{Kanp2025,
  author = {Kanp, Tanmoy and Dhuri, Anish and Aalhate, Mayur and Manoharan, Bharath and Rode, Khushi and Munagalasetty, Sharon and Sarma, Akella V S and Kshirsagar, Prasad and Shankaraiah, Nagula and Bhandari, Vasundhara and Sharma, Bhagwati and Singh, Pankaj Kumar},
  title = {Investigation of a Palbociclib and Naringin Co-Amorphous System to Ameliorate Anticancer Potential: Insights on In Silico Modeling, Physicochemical Characterization, Ex Vivo Permeation, and In Vitro Efficacy},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.4c01224}
}
Kostenlos starten →